ID OPRM_MOUSE Reviewed; 398 AA. AC P42866-1; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 1. DT 27-MAR-2024, entry version 196. DE RecName: Full=Isoform 1 of Mu-type opioid receptor; DE Short=M-OR-1; DE Short=MOR-1; GN Name=Oprm1; Synonyms=Mor, Oprm; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=C57BL/6J; TISSUE=Liver; RX PubMed=8090773; DOI=10.1073/pnas.91.19.9081; RA Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., Loh H.H.; RT "Genomic structure analysis of promoter sequence of a mouse mu opioid RT receptor gene."; RL Proc. Natl. Acad. Sci. U.S.A. 91:9081-9085(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=7649256; DOI=10.1016/0014-5793(95)00757-z; RA Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W.; RT "Antisense mapping the MOR-1 opioid receptor: evidence for alternative RT splicing and a novel morphine-6 beta-glucuronide receptor."; RL FEBS Lett. 369:192-196(1995). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR LOCATION. RC STRAIN=BALB/cJ; TISSUE=Brain; RX PubMed=7797593; DOI=10.1074/jbc.270.26.15877; RA Kaufman D.L., Keith D.E., Anton B., Tian J., Magendzo K., Newman D., RA Tran T., Lee D.S., Wen C., Xia Y., Lusis A.J., Evans C.J.; RT "Characterization of the murine mu opioid receptor gene."; RL J. Biol. Chem. 270:15877-15883(1995). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 8; 9 AND 10). RC STRAIN=C57BL/6J; RX PubMed=10419560; DOI=10.1124/mol.56.2.396; RA Pan Y.X., Xu J., Bolan E., Abbadie C., Chang A., Zuckerman A., Rossi G., RA Pasternak G.W.; RT "Identification and characterization of three new alternatively spliced mu- RT opioid receptor isoforms."; RL Mol. Pharmacol. 56:396-403(1999). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC STRAIN=CD-1; RA Pan Y.-X., Xu J., Chang A., Pasternak G.W.; RT "Identification and characterization of a mouse spliced mu-opioid receptor RT isoform (MOR-1A)."; RL Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 11). RC STRAIN=CD-1; RX PubMed=10682855; DOI=10.1016/s0014-5793(00)01095-4; RA Pan Y.X., Xu J., Bolan E., Chang A., Mahurter L., Rossi G., Pasternak G.W.; RT "Isolation and expression of a novel alternatively spliced mu opioid RT receptor isoform, MOR-1F."; RL FEBS Lett. 466:337-340(2000). RN [7] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=C57BL/6By x BALB/cBy; TISSUE=Brain; RX PubMed=11160404; DOI=10.1523/jneurosci.21-04-01334.2001; RA Ikeda K., Kobayashi T., Ichikawa T., Kumanishi T., Niki H., Yano R.; RT "The untranslated region of (mu)-opioid receptor mRNA contributes to RT reduced opioid sensitivity in CXBK mice."; RL J. Neurosci. 21:1334-1339(2001). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 14; 15 AND 16). RC STRAIN=C57BL/6By x BALB/cBy; RX PubMed=11717463; DOI=10.1073/pnas.241296098; RA Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., Pasternak G.W.; RT "Generation of the mu opioid receptor (MOR-1) protein by three new splice RT variants of the Oprm gene."; RL Proc. Natl. Acad. Sci. U.S.A. 98:14084-14089(2001). RN [9] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 13). RA Pan Y., Xu J., Xu M., Pasternak G.W.; RT "Identification and characterization of a novel splice variant from mouse RT mu opioid receptor gene (Oprm)."; RL Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 12). RC STRAIN=CD-1; RA Xu J., Pasternak G.W.; RT "Identification and characterization of a new isoform from mouse mu opioid RT receptor gene Oprm."; RL Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases. RN [11] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4; 5; 6 AND 7). RC STRAIN=CD-1; RX PubMed=15939800; DOI=10.1124/mol.105.011858; RA Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., Pasternak G.W.; RT "Identification of four novel exon 5 splice variants of the mouse mu-opioid RT receptor gene: functional consequences of C-terminal splicing."; RL Mol. Pharmacol. 68:866-875(2005). RN [12] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8). RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [13] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 10; 17; 18 AND 19). RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=17398041; DOI=10.1016/j.gene.2007.02.004; RA Doyle G.A., Sheng X.R., Lin S.S., Press D.M., Grice D.E., Buono R.J., RA Ferraro T.N., Berrettini W.H.; RT "Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice RT variants containing a newly identified alternatively spliced exon."; RL Gene 395:98-107(2007). RN [14] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [15] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [16] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [17] RP FUNCTION. RX PubMed=6933569; DOI=10.1073/pnas.77.9.5512; RA Inturrisi C.E., Umans J.G., Wolff D., Stern A.S., Lewis R.V., Stein S., RA Udenfriend S.; RT "Analgesic activity of the naturally occurring heptapeptide RT [Met]enkephalin-Arg6-Phe7."; RL Proc. Natl. Acad. Sci. U.S.A. 77:5512-5514(1980). RN [18] RP FUNCTION. RX PubMed=9037090; DOI=10.1073/pnas.94.4.1544; RA Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., RA Miner L.L., Uhl G.R.; RT "Opiate receptor knockout mice define mu receptor roles in endogenous RT nociceptive responses and morphine-induced analgesia."; RL Proc. Natl. Acad. Sci. U.S.A. 94:1544-1549(1997). RN [19] RP FUNCTION, AND COUPLING TO GNAZ. RX PubMed=9767386; DOI=10.1046/j.1460-9568.1998.00267.x; RA Garzon J., Castro M., Sanchez-Blazquez P.; RT "Influence of Gz and Gi2 transducer proteins in the affinity of opioid RT agonists to mu receptors."; RL Eur. J. Neurosci. 10:2557-2564(1998). RN [20] RP RECEPTOR HETEROOLIGOMERIZATION, FUNCTION, AND INTERACTION WITH OPRD1. RX PubMed=10842167; DOI=10.1074/jbc.m000345200; RA George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., O'Dowd B.F.; RT "Oligomerization of mu- and delta-opioid receptors. Generation of novel RT functional properties."; RL J. Biol. Chem. 275:26128-26135(2000). RN [21] RP RECEPTOR HETEROOLIGOMERIZATION, AND INTERACTION WITH OPRL1. RX PubMed=12270145; DOI=10.1016/s0006-291x(02)02258-1; RA Pan Y.X., Bolan E., Pasternak G.W.; RT "Dimerization of morphine and orphanin FQ/nociceptin receptors: generation RT of a novel opioid receptor subtype."; RL Biochem. Biophys. Res. Commun. 297:659-663(2002). RN [22] RP FUNCTION, RECEPTOR DESENSITIZATION, SUBCELLULAR LOCATION, AND RECEPTOR RP INTERNALIZATION. RX PubMed=12642578; DOI=10.1074/jbc.m300525200; RA Borgland S.L., Connor M., Osborne P.B., Furness J.B., Christie M.J.; RT "Opioid agonists have different efficacy profiles for G protein activation, RT rapid desensitization, and endocytosis of mu-opioid receptors."; RL J. Biol. Chem. 278:18776-18784(2003). RN [23] RP RECEPTOR RECYCLING, AND MUTAGENESIS OF LEU-387 AND LEU-390. RX PubMed=12939277; DOI=10.1074/jbc.m304504200; RA Tanowitz M., von Zastrow M.; RT "A novel endocytic recycling signal that distinguishes the membrane RT trafficking of naturally occurring opioid receptors."; RL J. Biol. Chem. 278:45978-45986(2003). RN [24] RP ALTERNATIVE SPLICING. RX PubMed=14991152; DOI=10.1007/s00109-003-0514-z; RA Kvam T.M., Baar C., Rakvag T.T., Kaasa S., Krokan H.E., Skorpen F.; RT "Genetic analysis of the murine mu opioid receptor: increased complexity of RT Oprm gene splicing."; RL J. Mol. Med. 82:250-255(2004). RN [25] RP FUNCTION, AND INTERACTION WITH RGS17 AND RGS20. RX PubMed=15827571; DOI=10.1038/sj.npp.1300726; RA Garzan J., Rodriguez-Munoz M., Lopez-Fando A., Sanchez-Blazquez P.; RT "The RGSZ2 protein exists in a complex with mu-opioid receptors and RT regulates the desensitizing capacity of Gz proteins."; RL Neuropsychopharmacology 30:1632-1648(2005). RN [26] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=16682964; DOI=10.1038/sj.bjp.0706757; RA Rios C., Gomes I., Devi L.A.; RT "mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition RT of receptor signaling and neuritogenesis."; RL Br. J. Pharmacol. 148:387-395(2006). RN [27] RP FUNCTION, AND INTERACTION WITH RGS9. RX PubMed=17725581; DOI=10.1111/j.1471-4159.2007.04812.x; RA Psifogeorgou K., Papakosta P., Russo S.J., Neve R.L., Kardassis D., RA Gold S.J., Zachariou V.; RT "RGS9-2 is a negative modulator of mu-opioid receptor function."; RL J. Neurochem. 103:617-625(2007). RN [28] RP INTERACTION WITH PPP1R9B. RX PubMed=18439408; DOI=10.1016/j.neuron.2008.02.006; RA Charlton J.J., Allen P.B., Psifogeorgou K., Chakravarty S., Gomes I., RA Neve R.L., Devi L.A., Greengard P., Nestler E.J., Zachariou V.; RT "Multiple actions of spinophilin regulate mu opioid receptor function."; RL Neuron 58:238-247(2008). RN [29] RP UBIQUITINATION, RECEPTOR HETEROOLIGOMERIZATION, AND INTERACTION WITH OPRD1 RP AND RTP4. RX PubMed=18836069; DOI=10.1073/pnas.0804106105; RA Decaillot F.M., Rozenfeld R., Gupta A., Devi L.A.; RT "Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4."; RL Proc. Natl. Acad. Sci. U.S.A. 105:16045-16050(2008). RN [30] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [31] RP FUNCTION (ISOFORM 9), AND INTERACTION WITH GRPR. RX PubMed=22000021; DOI=10.1016/j.cell.2011.08.043; RA Liu X.Y., Liu Z.C., Sun Y.G., Ross M., Kim S., Tsai F.F., Li Q.F., RA Jeffry J., Kim J.Y., Loh H.H., Chen Z.F.; RT "Unidirectional cross-activation of GRPR by MOR1D uncouples itch and RT analgesia induced by opioids."; RL Cell 147:447-458(2011). RN [32] RP INTERACTION WITH HINT1. RX PubMed=21153910; DOI=10.1007/s00018-010-0598-x; RA Rodriguez-Munoz M., Sanchez-Blazquez P., Vicente-Sanchez A., Bailon C., RA Martin-Aznar B., Garzon J.; RT "The histidine triad nucleotide-binding protein 1 supports mu-opioid RT receptor-glutamate NMDA receptor cross-regulation."; RL Cell. Mol. Life Sci. 68:2933-2949(2011). RN [33] RP RECEPTOR HETEROOLIGOMERIZATION, FUNCTION, AND INTERACTION WITH OPRD1. RX PubMed=21422164; DOI=10.1124/jpet.111.179093; RA Milan-Lobo L., Whistler J.L.; RT "Heteromerization of the mu- and delta-opioid receptors produces ligand- RT biased antagonism and alters mu-receptor trafficking."; RL J. Pharmacol. Exp. Ther. 337:868-875(2011). RN [34] RP FUNCTION. RX PubMed=35201898; DOI=10.1126/science.abl5130; RA Trieu B.H., Remmers B.C., Toddes C., Brandner D.D., Lefevre E.M., RA Kocharian A., Retzlaff C.L., Dick R.M., Mashal M.A., Gauthier E.A., Xie W., RA Zhang Y., More S.S., Rothwell P.E.; RT "Angiotensin-converting enzyme gates brain circuit-specific plasticity via RT an endogenous opioid."; RL Science 2022:eabl5130-eabl5130(2022). RN [35] RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 52-360 IN COMPLEX WITH MORPHINAN RP ANTAGONIST, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, AND DISULFIDE BOND. RX PubMed=22437502; DOI=10.1038/nature10954; RA Manglik A., Kruse A.C., Kobilka T.S., Thian F.S., Mathiesen J.M., RA Sunahara R.K., Pardo L., Weis W.I., Kobilka B.K., Granier S.; RT "Crystal structure of the micro-opioid receptor bound to a morphinan RT antagonist."; RL Nature 485:321-326(2012). RN [36] {ECO:0007744|PDB:5C1M} RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 52-347 IN COMPLEX WITH MORPHINAN RP AGONIST, FUNCTION, INTERACTION WITH GNAI1; GNB1 AND GNG2, SUBUNIT, RP DISULFIDE BONDS, SUBCELLULAR LOCATION, AND TOPOLOGY. RX PubMed=26245379; DOI=10.1038/nature14886; RA Huang W., Manglik A., Venkatakrishnan A.J., Laeremans T., Feinberg E.N., RA Sanborn A.L., Kato H.E., Livingston K.E., Thorsen T.S., Kling R.C., RA Granier S., Gmeiner P., Husbands S.M., Traynor J.R., Weis W.I., RA Steyaert J., Dror R.O., Kobilka B.K.; RT "Structural insights into u-opioid receptor activation."; RL Nature 524:315-321(2015). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=19; CC Comment=Additional isoforms seem to exist. Functional relevance for CC short isoforms with one transmembrane domain only is unsure and these CC isoforms are not included.; CC Name=1; Synonyms=MOR-1, MOR-H, MOR-1J, MOR-1T; CC IsoId=P42866-1; Sequence=Displayed; CC Name=2; Synonyms=MOR-1A; CC IsoId=P42866-2; Sequence=VSP_042339; CC Name=3; Synonyms=MOR-1B1; CC IsoId=P42866-3; Sequence=VSP_042340; CC Name=4; Synonyms=MOR-1B2; CC IsoId=P42866-4; Sequence=VSP_042341; CC Name=5; Synonyms=MOR-1B3, MOR-1Q; CC IsoId=P42866-5; Sequence=VSP_042342; CC Name=6; Synonyms=MOR-1B4, MOR-1R; CC IsoId=P42866-6; Sequence=VSP_042343; CC Name=7; Synonyms=MOR-1B5, MOR-1P; CC IsoId=P42866-7; Sequence=VSP_042344; CC Name=8; Synonyms=MOR-1C; CC IsoId=P42866-8; Sequence=VSP_042345; CC Name=9; Synonyms=MOR-1D; CC IsoId=P42866-9; Sequence=VSP_042346; CC Name=10; Synonyms=MOR-1E, MOR-1Eiii, MOR-1Eiv; CC IsoId=P42866-10; Sequence=VSP_042333; CC Name=11; Synonyms=MOR-1F; CC IsoId=P42866-11; Sequence=VSP_042334; CC Name=12; Synonyms=MOR-1O; CC IsoId=P42866-12; Sequence=VSP_042335; CC Name=13; Synonyms=MOR-1P, MOR-1R; CC IsoId=P42866-13; Sequence=VSP_042336; CC Name=14; Synonyms=MOR-1G; CC IsoId=P42866-14; Sequence=VSP_042332; CC Name=15; Synonyms=MOR-1M; CC IsoId=P42866-15; Sequence=VSP_042332, VSP_042345; CC Name=16; Synonyms=MOR-1N; CC IsoId=P42866-16; Sequence=VSP_042332, VSP_042346; CC Name=17; Synonyms=MOR-1U; CC IsoId=P42866-17; Sequence=VSP_042337; CC Name=18; Synonyms=MOR-1V; CC IsoId=P42866-18; Sequence=VSP_042338; CC Name=19; Synonyms=MOR-1W; CC IsoId=P42866-19; Sequence=VSP_042347; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR CCDS; CCDS78787.1; -. DR RefSeq; NP_001289722.1; NM_001302793.1. DR ProteomicsDB; 294202; -. DR Ensembl; ENSMUST00000056385.14; ENSMUSP00000060590.8; ENSMUSG00000000766.19. DR Ensembl; ENSMUST00000092734.11; ENSMUSP00000090410.5; ENSMUSG00000000766.19. DR Ensembl; ENSMUST00000105607.8; ENSMUSP00000101232.2; ENSMUSG00000000766.19. DR UCSC; uc007efw.3; mouse. DR Proteomes; UP000000589; Chromosome 10. PE 1: Evidence at protein level; SQ SEQUENCE 398 AA; 44421 MW; DFE1C758E2DA197E CRC64; MDSSAGPGNI SDCSDPLAPA SCSPAPGSWL NLSHVDGNQS DPCGPNRTGL GGSHSLCPQT GSPSMVTAIT IMALYSIVCV VGLFGNFLVM YVIVRYTKMK TATNIYIFNL ALADALATST LPFQSVNYLM GTWPFGNILC KIVISIDYYN MFTSIFTLCT MSVDRYIAVC HPVKALDFRT PRNAKIVNVC NWILSSAIGL PVMFMATTKY RQGSIDCTLT FSHPTWYWEN LLKICVFIFA FIMPVLIITV CYGLMILRLK SVRMLSGSKE KDRNLRRITR MVLVVVAVFI VCWTPIHIYV IIKALITIPE TTFQTVSWHF CIALGYTNSC LNPVLYAFLD ENFKRCFREF CIPTSSTIEQ QNSARIRQNT REHPSTANTV DRTNHQLENL EAETAPLP //